Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| peripheral blood | 15 studies | 27% ± 6% | |
| lung | 11 studies | 29% ± 10% | |
| intestine | 8 studies | 25% ± 10% | |
| bone marrow | 5 studies | 23% ± 5% | |
| lymph node | 5 studies | 29% ± 9% | |
| kidney | 4 studies | 27% ± 6% | |
| placenta | 4 studies | 43% ± 25% | |
| uterus | 4 studies | 31% ± 15% | |
| liver | 4 studies | 26% ± 11% | |
| pancreas | 3 studies | 49% ± 12% | |
| brain | 3 studies | 28% ± 3% | |
| breast | 3 studies | 18% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 10364.14 | 180 / 180 | 100% | 315.26 | 430 / 430 |
| pancreas | 100% | 11233.37 | 328 / 328 | 100% | 257.72 | 178 / 178 |
| prostate | 100% | 6728.57 | 245 / 245 | 100% | 338.26 | 502 / 502 |
| uterus | 100% | 9084.56 | 170 / 170 | 100% | 355.08 | 459 / 459 |
| esophagus | 100% | 6471.56 | 1444 / 1445 | 100% | 217.88 | 183 / 183 |
| lung | 100% | 9192.69 | 578 / 578 | 100% | 338.05 | 1154 / 1155 |
| thymus | 100% | 9911.14 | 653 / 653 | 100% | 280.86 | 604 / 605 |
| skin | 100% | 11379.57 | 1809 / 1809 | 100% | 404.74 | 471 / 472 |
| stomach | 100% | 8150.87 | 359 / 359 | 100% | 317.44 | 285 / 286 |
| breast | 100% | 7684.47 | 459 / 459 | 99% | 291.73 | 1112 / 1118 |
| intestine | 100% | 7509.12 | 966 / 966 | 99% | 366.34 | 524 / 527 |
| bladder | 100% | 7637.86 | 21 / 21 | 99% | 373.25 | 500 / 504 |
| kidney | 100% | 7041.88 | 89 / 89 | 99% | 241.24 | 891 / 901 |
| liver | 100% | 5814.15 | 225 / 226 | 99% | 190.94 | 403 / 406 |
| adrenal gland | 100% | 10514.49 | 258 / 258 | 94% | 169.04 | 216 / 230 |
| brain | 94% | 3040.52 | 2489 / 2642 | 99% | 178.82 | 701 / 705 |
| adipose | 100% | 7515.37 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 210.58 | 29 / 29 |
| spleen | 100% | 13582.67 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 288.34 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 140.15 | 1 / 1 |
| blood vessel | 100% | 7714.53 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 99% | 3765.35 | 795 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 212.68 | 79 / 80 |
| heart | 99% | 6537.44 | 849 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 98% | 7158.73 | 907 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0018279 | Biological process | protein N-linked glycosylation via asparagine |
| GO_0034097 | Biological process | response to cytokine |
| GO_0006487 | Biological process | protein N-linked glycosylation |
| GO_0042110 | Biological process | T cell activation |
| GO_0031647 | Biological process | regulation of protein stability |
| GO_0006486 | Biological process | protein glycosylation |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0008250 | Cellular component | oligosaccharyltransferase complex |
| GO_0035577 | Cellular component | azurophil granule membrane |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0008047 | Molecular function | enzyme activator activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | DDOST |
| Protein name | Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (DDOST 48 kDa subunit) (Oligosaccharyl transferase 48 kDa subunit) Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (Oligosaccharyl transferase 48 kDa subunit) |
| Synonyms | KIAA0115 OST48 OK/SW-cl.45 |
| Description | FUNCTION: Subunit of the oligosaccharyl transferase (OST) complex that catalyzes the initial transfer of a defined glycan (Glc(3)Man(9)GlcNAc(2) in eukaryotes) from the lipid carrier dolichol-pyrophosphate to an asparagine residue within an Asn-X-Ser/Thr consensus motif in nascent polypeptide chains, the first step in protein N-glycosylation . N-glycosylation occurs cotranslationally and the complex associates with the Sec61 complex at the channel-forming translocon complex that mediates protein translocation across the endoplasmic reticulum (ER). All subunits are required for a maximal enzyme activity (By similarity). Required for the assembly of both SST3A- and SS3B-containing OST complexes . . FUNCTION: Subunit of the oligosaccharyl transferase (OST) complex that catalyzes the initial transfer of a defined glycan (Glc(3)Man(9)GlcNAc(2) in eukaryotes) from the lipid carrier dolichol-pyrophosphate to an asparagine residue within an Asn-X-Ser/Thr consensus motif in nascent polypeptide chains, the first step in protein N-glycosylation. N-glycosylation occurs cotranslationally and the complex associates with the Sec61 complex at the channel-forming translocon complex that mediates protein translocation across the endoplasmic reticulum (ER). . FUNCTION: Subunit of the oligosaccharyl transferase (OST) complex that catalyzes the initial transfer of a defined glycan (Glc(3)Man(9)GlcNAc(2) in eukaryotes) from the lipid carrier dolichol-pyrophosphate to an asparagine residue within an Asn-X-Ser/Thr consensus motif in nascent polypeptide chains, the first step in protein N-glycosylation. N-glycosylation occurs cotranslationally and the complex associates with the Sec61 complex at the channel-forming translocon complex that mediates protein translocation across the endoplasmic reticulum (ER). . |
| Accessions | P39656 ENST00000602624.7 U3KQ84 ENST00000464364.1 A0A0C4DGS1 ENST00000415136.6 [P39656-1] |